Iron infusion acutely impairs FGF23 cleavage, triggering transient increase in intact FGF23 and hypophosphatemia in association with an inappropriately low concentration of 1,25(OH)2D, similar to genetic diseases of primary FGF23 excess (14, 31). The gene discussed is FGF23; the disease is hypophosphatemia.